NCCN Task Force: Clinical utility of PET in a variety of tumor types

Donald A. Podoloff, Douglas W Ball, Edgar Ben-Josef, Al B. Benson, Steven J. Cohen, R. Edward Coleman, Dominique Delbeke, Maria Ho, David H. Ilson, Gregory P. Kalemkerian, Richard J. Lee, Jay S. Loeffler, Homer A. Macapinlac, Robert J. Morgan, Barry Alan Siegel, Seema Singhal, Douglas S. Tyler, Richard J. Wong

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue numberSUPPL. 2
StatePublished - 2009

    Fingerprint

Keywords

  • Biliary tract cancer
  • Brain cancer
  • Esophageal cancer
  • Gastric cancer
  • Genitourinary cancers
  • Gynecological cancers
  • Liver cancer
  • Myeloma
  • Pancreatic cancer
  • PET
  • PET/CT
  • Sarcoma
  • Small cell lung cancer
  • Thyroid cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Podoloff, D. A., Ball, D. W., Ben-Josef, E., Benson, A. B., Cohen, S. J., Coleman, R. E., Delbeke, D., Ho, M., Ilson, D. H., Kalemkerian, G. P., Lee, R. J., Loeffler, J. S., Macapinlac, H. A., Morgan, R. J., Siegel, B. A., Singhal, S., Tyler, D. S., & Wong, R. J. (2009). NCCN Task Force: Clinical utility of PET in a variety of tumor types. JNCCN Journal of the National Comprehensive Cancer Network, 7(SUPPL. 2).